Early initiation of antiviral therapy is crucial for achieving the best outcomes. For example, starting acyclovir within the first few days of life can significantly reduce the risk of severe complications in neonates with HSV. Similarly, initiating ganciclovir early in neonates with symptomatic CMV can prevent long-term sequelae.
